MFN Drug Pricing Targets: Lowering U.S. Drug Co...

By Rene Pretorius

May 21, 2025

Summary The U.S. Department of Health and Human Services (HHS) and the Centers for Medicare and Medicaid Services (CMS) have set Most-Favored-Nation (MFN)
EMA AI Tool Qualification: How the AIM-NASH Approval Sets a Roadmap for Medic...
A System Dynamics Approach to Lowering Drug Prices by 30–80% in the US
Canada Drug Agency Plan: Shaping the Future of Health Systems 2025-2030
VIETNARMS Trial Unveils Innovative Hepatitis C Treatment Options
Revolutionizing Hepatitis C Treatment: The Transformative Role of Direct-Acti...
First At-Home HPV Testing Approval: FDA Clears Teal Wand
MR-107A-02: Revolutionizing Non-Opioid Pain Management with Viatris’ Breakthr...
Bulevirtide HDV Therapy: Promising Results in Durable Virologic Control
HCV Treatment Advancements: Atea Pharmaceuticals KOL Panel
South Africa NHI Bill Court Ruling Calls for Scrutiny
TAVR Asymptomatic Approval: A New Era for Early Intervention in Aortic Stenosis
Wegovy CVS Deal: Hybrid Market Access Strategy Insights